John Howard Gregory

Enterprise VCT Plc's objectives are to provide the holders of ordinary shares with an attractive return and substantial protection of capital, the holders of a ordinary shares with the benefits of a venture capital portfolio which emphasises capital gain while seeking to lower risk by maintaining a balanced and diverse portfolio of investments by both number and sector and all Company shareholders with the personal tax benefits available through investment in venture capital trusts.

IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom.

Foresight 3 VCT Plc operates as a venture capital fund. Its objective is to provide private investors with attractive returns from a portfolio of investments in fast-growing unquoted companies in the United Kingdom. The company was founded on November 3, 1995 and is headquartered in Sevenoaks, the United Kingdom.

Amati Global Investors Ltd. (Venture Capital) is a Venture Capital firm, a subsidiary of Amati Global Investors Ltd. founded in 1999. The firm is headquartered in Edinburgh.

Singer & Friedlander Holdings Ltd. provided investment advice services. The company was headquartered in London, the United Kingdom.

Ansbacher & Co. Ltd. (A&Co) is the asset management arm and a subsidiary of Ansbacher Banking Group, which in turn is a wholly-owned subsidiary of QNB-Qatar National Bank (QA: QNBK) since 2004. QNB is controlled by the Government of Qatar. The group was founded in 1894 as a brokerage firm. Their current activities include investment advisory, multi-currency private banking services, super yatch finance, fiduciary structuring and margin lending. Based in London, the group has offices in Zurich, Dubai, the Channel Islands, the Bahamas and Doha in Qatar. A&Co specializes in global wealth management, both onshore and offshore, and provides tailored financial solutions to an international clientele of high-net worth private individuals, trustees, institutions and corporations. The firm provides investment advisory services and manages trusts and discretionary accounts, delegating specialist portfolios to third-party asset management firms and using an open architecture approach. A&Co also manages the Al Watani equity funds for QNB, which are invested in the Qatari economy.

Sinclair Pharma Ltd. operates as an aesthetic dermatology company which provides solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain. The International Operations segment focuses on the sale through a local distributor. The company was founded in 1971 and is headquartered in London, the United Kingdom.

Sphere Medical Holding Ltd. was engaged in the development of medical monitoring and diagnostic equipment. It focuses on the development of Proxima, which is a platform for measuring blood gases, electrolytes, and metabolites; and Pelorus, which helps in the management of sedation and intravenous anesthesia. The company was founded by Stuart Paul Hendry and Gavin Troughton on March 14, 2001 and was headquartered in London, the United Kingdom.